Exploring the Safety and Efficacy of Medical Termination of Pregnancy: A Comprehensive Review
- PMID: 37927767
- PMCID: PMC10622735
- DOI: 10.7759/cureus.46444
Exploring the Safety and Efficacy of Medical Termination of Pregnancy: A Comprehensive Review
Abstract
Medical termination of pregnancy, also known as medication abortion, is a safe and effective method of terminating pregnancies in the early stages. It involves using medications, such as mifepristone and prostaglandin, to induce a miscarriage. The success rates of medical abortion vary depending on factors such as gestational age and the specific medications used. For pregnancies that are 49 days or less, the success rates range from 92% to 98%. The choice between misoprostol and gemeprost, both prostaglandins, does not significantly impact the outcomes. It is important to note that various factors, including study design, definitions of success, and prior experience with medical abortion may influence success rates. Strict criteria for success and limited familiarity with the procedure may result in lower reported success rates. Medical termination of pregnancy should be carried out under the guidance and supervision of healthcare professionals. It is crucial to consult a healthcare provider to receive accurate information, personalized guidance, and appropriate support throughout the process. Each situation is unique, and decisions regarding medical termination of pregnancy should be made in collaboration with a trusted healthcare provider.
Keywords: 24 weeks; abortion; gestational age; mifepristone; misoprostol.
Copyright © 2023, Leichombam et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Induction of abortion with mifepristone and misoprostol in early pregnancy.Br J Obstet Gynaecol. 1992 Dec;99(12):1004-7. doi: 10.1111/j.1471-0528.1992.tb13707.x. Br J Obstet Gynaecol. 1992. PMID: 1477003
-
The efficacy of medical abortion: a meta-analysis.Contraception. 2000 Jan;61(1):29-40. doi: 10.1016/s0010-7824(99)00115-8. Contraception. 2000. PMID: 10745067
-
Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.Hum Reprod. 1995 Jun;10(6):1521-7. doi: 10.1093/humrep/10.6.1521. Hum Reprod. 1995. PMID: 7593528 Clinical Trial.
-
[Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].J Gynecol Obstet Biol Reprod (Paris). 2014 Feb;43(2):123-45. doi: 10.1016/j.jgyn.2013.11.007. Epub 2014 Jan 13. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 24433988 Review. French.
-
Efficacy of medical abortion prior to 6 gestational weeks: a systematic review.Contraception. 2018 Feb;97(2):90-99. doi: 10.1016/j.contraception.2017.09.006. Epub 2017 Sep 18. Contraception. 2018. PMID: 28935220
Cited by
-
Asoprisnil as a Novel Ligand Interacting with Stress-Associated Glucocorticoid Receptor.Biomedicines. 2024 Nov 30;12(12):2745. doi: 10.3390/biomedicines12122745. Biomedicines. 2024. PMID: 39767652 Free PMC article.
References
-
- Medical approaches to termination of early pregnancy. Van Look PF, Bygdeman M. https://pubmed.ncbi.nlm.nih.gov/2692870/ Bull World Health Organ. 1989;67:567–575. - PMC - PubMed
-
- Amnioinfusion: from termination of pregnancy to therapy. Contro E, Jauniaux E. BJOG. 2021;128:303. - PubMed
-
- COMMENT: The Medical Termination of Pregnancy (Amendment) Act, 2021: a step towards liberation. Arora V, Verma IC. Indian J Med Ethics. 2022;VII:1–7. - PubMed
-
- Comparison of groups with medical and surgical terminations of pregnancy. Pojarová M, Sehnal B, Jarolímková A, Neumannová H, Zikán M. https://pubmed.ncbi.nlm.nih.gov/30441954/ Ceska Gynekol. 2018;83:244–249. - PubMed
Publication types
LinkOut - more resources
Full Text Sources